Avalanche Bio Downgraded At William Blair, Firm Says Phase IIb 'A Ways Away'
June 16, 2015 at 07:10 AM EDT
In a report published Tuesday, William Blair analyst Tim Lugo downgraded the rating on Avalanche Biotechnologies Inc (NASDAQ: AAVL) from ...